Cargando…
Advances in NKT cell Immunotherapy for Glioblastoma
Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108592/ https://www.ncbi.nlm.nih.gov/pubmed/30147849 http://dx.doi.org/10.4172/1948-5956.1000533 |
_version_ | 1783350168117051392 |
---|---|
author | Pyaram, Kalyani Yadav, Viveka Nand |
author_facet | Pyaram, Kalyani Yadav, Viveka Nand |
author_sort | Pyaram, Kalyani |
collection | PubMed |
description | Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR – Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11. |
format | Online Article Text |
id | pubmed-6108592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-61085922018-08-24 Advances in NKT cell Immunotherapy for Glioblastoma Pyaram, Kalyani Yadav, Viveka Nand J Cancer Sci Ther Article Type I or invariant natural killer T cells belong to a unique lineage of innate T cells, which express markers of both T lymphocytes and NK cells, namely T cell receptor (TCR) and NK1.1 (CD161C), respectively. Thus, apart from direct killing of target cells like NK cells, and they also produce a myriad of cytokines which modulate the adaptive immune responses. Unlike traditional T cells which carry a conventional αβ TCR, NKT cells express semi-invariant TCR – Vα14-Jα18, coupled with Vβ8, Vβ7 and Vβ2 in mice. In humans, the invariant TCR is composed of Vα24-Jα18, coupled with Vβ11. 2018-06-18 2018 /pmc/articles/PMC6108592/ /pubmed/30147849 http://dx.doi.org/10.4172/1948-5956.1000533 Text en This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Article Pyaram, Kalyani Yadav, Viveka Nand Advances in NKT cell Immunotherapy for Glioblastoma |
title | Advances in NKT cell Immunotherapy for Glioblastoma |
title_full | Advances in NKT cell Immunotherapy for Glioblastoma |
title_fullStr | Advances in NKT cell Immunotherapy for Glioblastoma |
title_full_unstemmed | Advances in NKT cell Immunotherapy for Glioblastoma |
title_short | Advances in NKT cell Immunotherapy for Glioblastoma |
title_sort | advances in nkt cell immunotherapy for glioblastoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108592/ https://www.ncbi.nlm.nih.gov/pubmed/30147849 http://dx.doi.org/10.4172/1948-5956.1000533 |
work_keys_str_mv | AT pyaramkalyani advancesinnktcellimmunotherapyforglioblastoma AT yadavvivekanand advancesinnktcellimmunotherapyforglioblastoma |